Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
05 2019
Historique:
received: 08 01 2019
accepted: 16 04 2019
entrez: 28 5 2019
pubmed: 28 5 2019
medline: 22 7 2020
Statut: epublish

Résumé

Awareness that traditional two-dimensional (2D) in vitro and nonrepresentative animal models may not completely emulate the 3D hierarchical complexity of tissues and organs is on the rise. Therefore, posterior translation into successful clinical application is compromised. To address this dearth, on-chip biomimetic microenvironments powered by microfluidic technologies are being developed to better capture the complexity of in vivo pathophysiology. Here, we describe a "tumor-on-a-chip" model for assessment of precision nanomedicine delivery on which we validate the efficacy of drug-loaded nanoparticles in a gradient fashion. The model validation was performed by viability studies integrated with live imaging to confirm the dose-response effect of cells exposed to the CMCht/PAMAM nanoparticle gradient. This platform also enables the analysis at the gene expression level, where a down-regulation of all the studied genes (

Identifiants

pubmed: 31131324
doi: 10.1126/sciadv.aaw1317
pii: aaw1317
pmc: PMC6531003
doi:

Substances chimiques

Dendrimers 0
Ki-67 Antigen 0
PAMAM Starburst 0
CASP3 protein, human EC 3.4.22.-
Caspase 3 EC 3.4.22.-
MMP1 protein, human EC 3.4.24.7
Matrix Metalloproteinase 1 EC 3.4.24.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaaw1317

Références

Braz J Med Biol Res. 2013 Jul;46(7):634-42
pubmed: 23903680
J Colloid Interface Sci. 2017 Dec 1;507:217-224
pubmed: 28800445
Nat Protoc. 2017 May;12(5):865-880
pubmed: 28358393
Nanomedicine (Lond). 2017 Mar;12(6):581-596
pubmed: 28186438
Lab Chip. 2015 Nov 21;15(22):4242-55
pubmed: 26364747
PLoS One. 2017 Mar 23;12(3):e0174487
pubmed: 28334049
J Biol Chem. 2012 Jul 13;287(29):24330-8
pubmed: 22573325
Acta Biomater. 2016 Apr 1;34:1-20
pubmed: 26361719
Int J Nanomedicine. 2015 Oct 30;10:6825-34
pubmed: 26586944
Sci Rep. 2016 Nov 07;6:36440
pubmed: 27819270
Lab Chip. 2017 Jan 31;17(3):511-520
pubmed: 28092382
Anticancer Res. 2011 Sep;31(9):2971-4
pubmed: 21868546
Curr Opin Cell Biol. 2015 Oct;36:23-31
pubmed: 26186729
J Gastrointest Surg. 2004 Dec;8(8):1072-8
pubmed: 15585396
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13515-20
pubmed: 22869695
Lab Chip. 2012 Sep 21;12(18):3249-66
pubmed: 22859057
Biomaterials. 2009 Feb;30(5):804-13
pubmed: 19036432
J Cell Biol. 2004 Oct 25;167(2):223-9
pubmed: 15504909
Lab Chip. 2014 Sep 7;14(17):3241-7
pubmed: 25008971
Iran J Basic Med Sci. 2012 Nov;15(6):1110-26
pubmed: 23653839
Scand J Gastroenterol. 2007 Dec;42(12):1473-8
pubmed: 17852862
World J Gastroenterol. 2015 Nov 7;21(41):11767-76
pubmed: 26557001
Biomed Microdevices. 2014 Feb;16(1):91-6
pubmed: 24065585
Cancers (Basel). 2014 Feb 10;6(1):366-75
pubmed: 24518611
Lab Chip. 2012 Aug 21;12(16):2815-22
pubmed: 22767334
Genes Cells. 2012 Feb;17(2):83-97
pubmed: 22244258
J Clin Pathol. 2016 Mar;69(3):209-14
pubmed: 26281861
Clin Cancer Res. 1999 Jan;5(1):203-8
pubmed: 9918220
Clin Transl Oncol. 2015 May;17(5):384-92
pubmed: 25428757
Sci Rep. 2017 Dec 1;7(1):16724
pubmed: 29196753
Cancer Sci. 2017 Jul;108(7):1357-1367
pubmed: 28421697
Cell Mol Biol Lett. 2011 Mar;16(1):101-13
pubmed: 21225469
Vasc Health Risk Manag. 2006;2(3):213-9
pubmed: 17326328
Am J Cancer Res. 2017 May 01;7(5):1016-1036
pubmed: 28560055
Kaohsiung J Med Sci. 2014 Jul;30(7):323-30
pubmed: 24924837
Biomaterials. 2010 Nov;31(32):8454-64
pubmed: 20684983
Lab Chip. 2008 Jan;8(1):34-57
pubmed: 18094760
Libyan J Med. 2017 Dec;12(1):1290741
pubmed: 28245709
Biomed Microdevices. 2017 Sep 7;19(4):81
pubmed: 28884359
Biomed Pharmacother. 2018 Jun;102:1203-1208
pubmed: 29710539
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6712-7
pubmed: 23569284
J Cell Mol Med. 2015 Feb;19(2):340-50
pubmed: 25331547
Stem Cell Rev Rep. 2017 Jun;13(3):347-363
pubmed: 28233276

Auteurs

M R Carvalho (MR)

3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Guimarães, Portugal.

D Barata (D)

Department of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.

L M Teixeira (LM)

Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.

S Giselbrecht (S)

Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.

R L Reis (RL)

3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Guimarães, Portugal.

J M Oliveira (JM)

3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Guimarães, Portugal.

R Truckenmüller (R)

Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.
300MICRONS GmbH, Daimlerstraße 35, 76185 Karlsruhe, Germany.

P Habibovic (P)

Department of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH